0001178913-16-007198.txt : 20161229 0001178913-16-007198.hdr.sgml : 20161229 20161229163018 ACCESSION NUMBER: 0001178913-16-007198 CONFORMED SUBMISSION TYPE: 25 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20161229 DATE AS OF CHANGE: 20161229 EFFECTIVENESS DATE: 20161229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Evogene Ltd. CENTRAL INDEX KEY: 0001574565 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36187 FILM NUMBER: 162075455 BUSINESS ADDRESS: STREET 1: 13 GAD FEINSTEIN STREET STREET 2: PARK REHOVOT P.O.B 2100 CITY: REHOVOT STATE: L3 ZIP: 76121 BUSINESS PHONE: 97289311900 MAIL ADDRESS: STREET 1: 13 GAD FEINSTEIN STREET STREET 2: PARK REHOVOT P.O.B 2100 CITY: REHOVOT STATE: L3 ZIP: 76121 25 1 zk1619320.htm FORM 25

 
UNITED STATES
OMB APPROVAL
 
SECURITIES AND EXCHANGE COMMISSION
OMB Number:
Expires:
Estimated average burden
hours per response:
3235-0080
March 31, 2018
 
1.7
 
Washington, D.C. 20549
  FORM 25
 
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.
 
Commission File Number  001-36187
 
 
Issuer:
Evogene Ltd. 
 
Exchange:
The New York Stock Exchange
(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)
Address:
 13 Gad Feinstein Street  
  Park Rehovot, P.O.B 2100  
   
Rehovot 7612002 Israel
  
       
 
Telephone number:   +972-8-931-1900 
(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)
Ordinary Shares par value NIS 0.02 per share
(Description of class of securities)
 
Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:
 
 
☐
17 CFR 240.12d2-2(a)(1)
 
 
☐
17 CFR 240.12d2-2(a)(2)
 
 
☐
17 CFR 240.12d2-2(a)(3)
 
 
☐
17 CFR 240.12d2-2(a)(4)
 
 
☐
Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1
 
 
☑
Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, Evogene Ltd. certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.
 
 
Evogene Ltd.
  
       
By:
/s/ Eyal Leibovitz  
    Eyal Leibovitz  
    Chief Financial Officer  
       
Dated: December 29, 2016